Jeppson Wealth Management LLC Makes New $33,000 Investment in Tilray Inc (NASDAQ:TLRY)

Jeppson Wealth Management LLC bought a new position in shares of Tilray Inc (NASDAQ:TLRY) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 20,000 shares of the company’s stock, valued at approximately $33,000.

Several other institutional investors have also recently made changes to their positions in TLRY. Prospect Financial Services LLC purchased a new position in shares of Tilray during the second quarter worth $26,000. RPO LLC acquired a new stake in shares of Tilray in the fourth quarter valued at about $28,000. Simplicity Wealth LLC acquired a new stake in shares of Tilray in the first quarter valued at about $28,000. Gainplan LLC acquired a new stake in shares of Tilray in the fourth quarter valued at about $28,000. Finally, Wellington Wealth Strategies LLC. acquired a new position in Tilray during the fourth quarter worth about $29,000. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Price Performance

TLRY traded down $0.02 on Friday, reaching $1.67. 1,832,336 shares of the company’s stock were exchanged, compared to its average volume of 25,202,055. The stock has a market cap of $1.29 billion, a PE ratio of -3.82 and a beta of 2.19. Tilray Inc has a twelve month low of $1.50 and a twelve month high of $3.37. The stock’s fifty day moving average price is $1.82 and its 200-day moving average price is $1.88. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.27 and a quick ratio of 1.42.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. During the same quarter in the previous year, the firm posted ($0.15) earnings per share. The business’s revenue was up 24.8% compared to the same quarter last year. Sell-side analysts expect that Tilray Inc will post -0.12 EPS for the current year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.